CSAM Health Group AS – Successfully completed bond tap issue

On 27 September 2023, CSAM Health Group AS changed its name to Omda AS. For articles on historical events such as transactions, financial results etc. we will not retroactively change the name.
___

CSAM Health Group AS (the “Company”) has today successfully completed a tap issue of NOK 200 million under the Company’s existing senior secured bond with maturity date 25 September 2024 and ISIN NO 0010893738.

The tap issue was completed at an issue price of 103.5% of the nominal amount, corresponding to an implied coupon of approximately 3m NIBOR + 390bps. Settlement of the tap issue is expected to take place on or about 29 April 2021. Following settlement, the outstanding amount under the bond will be NOK 500 million.

The proceeds from the tap issue will be used for general corporate purposes, including acquisitions.

Carnegie AS acted as financial adviser and sole bookrunner in connection with the tap issue.

For further information, please contact:
Einar Bonnevie, +47 91 55 45 32 or einar.bonnevie@csamhealth.com

 

About CSAM Health Group 

CSAM Health Group is an eHealth software company headquartered in Oslo, Norway, specializing in clinical niche solutions for hospitals. The Company is a leading Nordic niche software vendor to most health regions in Norway, Sweden, Denmark and Finland. After the recent acquisition of Carmenta’s Public Safety business, the company has also established presence in continental Europe. The majority of the Company’s’ customers are public healthcare providers in the Nordics, representing ~95% of sales in 2020.

CSAM Health Group was listed at the Euronext Growth in October 2020. The Company employs approx. 225 people, throughout offices in Norway (2), Sweden (4), Finland (3), Denmark (1), Spain (1) and the Philippines (1 – development and testing)

To learn more, please visit www.csamhealth.com.

This information is subject of the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act

Einar Bonnevie
Chief Financial Officer
Categories

Related News

Omda delivers 11% growth in Q4
Read More
Invitation to presentation of Omda’s Q4 results
Read More
Omda ProSang 10 Is A Significant Next Step For Omda’s Blood Management Solution
Read More
Partial repurchase of OMDA01
Read More

Get in touch

Please enable JavaScript in your browser to complete this form.
Name
Helen Døcker
Chief Marketing & Communications Officer
helen.docker@omda.com
She is based in the company’s headquarters in Oslo, Norway.

Join our conversation to build a safer and healthier world.